Showing results (161-170 of 178) with videos related to
Sort By:
Pageof 18
Autoimmunity Reviews|October 17, 2013
Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literatureI Marie, J-F Gehanno, M Bubenheim, et al.Genes & Cancer|March 7, 2012
Colorectal Neoplasia Differentially Expressed (CRNDE), a Novel Gene with Elevated Expression in Colorectal Adenomas and AdenocarcinomasLloyd D Graham, Susanne K Pedersen, Glenn S Brown, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|April 28, 2023
Effectiveness of mogamulizumab in patients with Mycosis Fungoides or Sézary syndrome: A multicentre, retrospective, real-world French studyM Beylot-Barry, G Quereux, C Nardin, et al.Epigenetics|May 7, 2014
CAHM, a long non-coding RNA gene hypermethylated in colorectal neoplasiaSusanne K Pedersen, Susan M Mitchell, Lloyd D Graham, et al.Foodborne Pathogens and Disease|July 5, 2012
Characterization of extended-spectrum cephalosporin-resistant Salmonella enterica serovar Heidelberg isolated from food animals, retail meat, and humans in the United States 2009J P Folster, G Pecic, A Singh, et al.BMC Cancer|October 8, 2015
Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasiaSusanne K Pedersen, Erin L Symonds, Rohan T Baker, et al.Genes|December 17, 2016
Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal CancerSusan M Mitchell, Thu Ho, Glenn S Brown, et al.Clinical Epigenetics|January 22, 2021
Evaluation of a panel of tumor-specific differentially-methylated DNA regions in IRF4, IKZF1 and BCAT1 for blood-based detection of colorectal cancerGraeme P Young, Erin L Symonds, Hans Jørgen Nielsen, et al.Annales De Dermatologie Et De Venereologie|February 12, 2013
[Changes in the incidence and mortality rates of malignant melanoma in the Seine-Maritime region over a 20-year period]C Le Blanc, C Corven, P Courville, et al.Leukemia|January 23, 2009
Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the diseaseF Jardin, M Callanan, D Penther, et al.Pageof 18